Enhanced workout recovery As a regular exerciser, faster recovery between workouts made a huge difference
Ozempic is FDA-approved for type 2 diabetes (doses up to 2 mg), while Wegovy is FDA-approved specifically for weight management at the higher 2.4 mg dose
The appetite suppression timeline for GLP-1 medications gives context for when reduced food intake typically begins affecting nutrient status
On average, patients start seeing significant weight changes after 8-12 weeks of consistent use
That is why we emphasize a personalized approach at TrimRx
Regarding the cardiovascular outcomes, when examining other individual components of MACE, the analysis showed no significant differences between combination therapy and GLP-1RA monotherapy or SGLT-2i monotherapy in terms of cardiovascular mortality, non-fatal myocardial infarction, stroke, and all-cause mortality (Fig